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ABSTRACT 
The increasing number of studies demonstrates the high potency of the intrathecal (IT) route for 
the delivery of biopharmaceuticals to the central nervous system (CNS). Our earlier data 
exhibited that both the infused volume and the infusion rate can regulate the initial disposition of 
the administered solute within the cerebrospinal fluid (CSF). This disposition is one of key 
factors in defining the subsequent transport of the solute to its intended target. On the other 
hand, fast additions of large volumes of liquid to the CSF inevitably raise the CSF pressure 
(a.k.a. intracranial pressure (ICP)), which may in turn lead to adverse reactions if the 
physiologically delimited threshold is exceeded. While long-term biological effects of elevated 
CSF pressure (hydrocephalus) are known, the safety thresholds pertaining to short-term ICP 
elevations caused by IT administrations have not yet been characterized. This study aimed to 
investigate the dynamics of ICP in rats and non-human primates (NHP) with respect to IT 
infusion rates and volumes. The safety regimes were estimated and analyzed across species to 
facilitate the development of translational large-volume IT therapies. The data revealed that the 
addition of a liquid to the CSF raised the ICP in a rate and volume-dependent manner. At low 
infusion rates (<0.12 ml/min in rats and <2 ml/min in NHP), NHP and rats displayed similar 
tolerance patterns. Specifically, safe accommodations of such added volumes were mainly 
facilitated by the accelerated pressure-dependent CSF drainage into the blood, with ICPs 
stabilizing at different levels below the safety threshold of 28±4 mm Hg in rats and 50±5 mm Hg 
in NHPs. These ICPs were safely tolerated for extended durations (of at least 2-25 min). High 
infusion rates (including boluses) caused uncompensated exponential ICP elevations rapidly 
exceeding the safety thresholds. Their tolerance was species-dependent and was facilitated by 
the compensatory role of the varied components of craniospinal compliance while not excluding 
the possibility of other contributing factors such as lymphatic drainage specifically in rats. In 
conclusion, large volumes of liquids can safely be delivered via IT routes provided that ICP is 
monitored as a safety factor and cross-species physiological differences accounted for. 
Keywords: Cerebrospinal fluid, intracranial pressure, intrathecal, drug delivery, CNS, CSF, 
craniospinal compliance, safety 
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INTRODUCTION 
 
The IT drug delivery route is of increasing interest due to the absence of continuous barriers 
between the CSF and CNS1, which makes the fraction of CSF-borne compounds delivered to 
the brain from the CSF through perivascular channels2,3,4 pharmacologically significant5,6,7,8,9,10. 
This is especially important for macromolecules, including biopharmaceuticals, for which the 
access to CNS from the systemic circulation is particularly hindered due to large molecular size 
and the presence of several vascular barriers (blood-brain, blood-arachnoid, and blood-CSF). 
11,12 
 
In the clinical setting, the most commonly used routes for accessing the CSF are: (1) the 
intrathecal lumbar (ITL) route through the lumbar cistern (enveloping the cauda equina) and (2) 
the more invasive intracerebroventricular (ICV) route through the brain parenchyma into one of 
the lateral ventricles of the brain. Although the ICV route is clinically feasible, it requires the 
surgical installation of a transcranial port with an accompanying cannula (Omaya reservoir). The 
ITL route can be utilized for chronic use (with surgical installation of subcutaneous ports or 
electronic pumps) as well as for one-dose injections directly through vertebral disks in the L3-L5 
region. Both methods are relatively simple, well developed, and particularly suitable for 
biopharmaceuticals, such as gene vectors, intended for single injections or multiple injections 
given at a large interval (several months).  
 
The ITL route is commonly used in pain and spasticity management for chronic delivery of 
respective drugs from subcutaneously implanted electronic pumps. Such pumps deliver very 
small volumes directly to the target (nerve roots). The action of the drug delivered in such a way 
is focal in nature in that it does not spread cranially along the spinal column. Our data obtained 
earlier in non-invasive PET studies showed that such local action was made possible due to the 
absence of directional CSF flow within the spine.5,13 We also found that the ITL administration of 
a larger volume caused immediate translocation of the administered solute to the cerebro-
cervical area, resulting in a nearly identical initial disposition in the CSF as compared to ICV 
administration.7 Rieselbach et al.14 demonstrated that both humans and non-human primates 
could tolerate large-volume ITL boluses of up to 33% and 42% of the total CSF volume, 
respectively. Therefore, the ITL route is currently of significant interest for both testing the 
efficacy of novel biopharmaceuticals in preclinical models as well as for clinical use. However, 
the physiological mechanisms responsible for the accommodation of such additional large 
volumes by the subarachnoid (leptomeningeal) space as well as the safety limits of different IT 
administration regimes remain unknown.  
 
Due to the confinement of the subarachnoid liquid-filled space by rigid (bone) boundaries, the 
modified Monroe-Kellie doctrine15 states that the total volume of its contents must remain 
constant. The brain, CSF, and blood are the major constituents, the volume fractions of which 
under normal conditions are 83%, 11%, and 6%, respectively. Given the constant volume of the 
brain tissue, it is the hydrodynamic balance of blood and CSF volumes that primarily determines 
the CSF pressure (often referred to as intracranial pressure, or ICP). In this respect, 
experimentally measurable characteristics of ICP can be evaluated as safety factors 
characterizing the impact of IT administrations. 
 
ICP is not constant and on a long-term scale (hours), depends on the balance of CSF 
production and drainage. On a shorter-term scale (seconds), ICP fluctuates due to the rhythmic 
changes of the cerebral blood volume. Such a dynamic nature of the ICP signal necessitates 
analysis of not only the mean value, but also of the ICP waveform16,17. The latter is 
characterized by periodic pulses each consisting of three notches P1, P2, and P3, progressively 
© 2020 Authors PREPRINT
	 4	
decreasing in amplitude and reflecting propagation of the arterial pulse pressure wave. P1 
harmonic is a fundamental component (percussion wave) that represents transmission of the 
arterial pulse through the choroid plexus to the CSF. The amplitude of this component and the 
average ICP are the key parameters used for characterizing the ICP autoregulatory capacity i.e. 
the ability to maintain a normal ICP. This capacity can be assessed by studying the ICP-CSF 
volume and the ICP amplitude-mean ICP relationships. There is significant evidence indicating 
the successful use of these relationships for deriving indices effective for the diagnosis and 
assessment of treatments for neurological disorders affecting the liquid homeostasis in the CNS 
such as subarachnoid and intracerebral hemorrhage, ischemic stroke, hydrocephalus, 
meningitis/encephalitis, and traumatic brain injury among others.16,17,18,19 
 
In humans, 7-15 mm Hg is considered a normal range of ICP as measured via lumbar access in 
supine adults.20 While ICP in humans is commonly reported for the supine position, the 
measured value is known to be a function of a body posture.17 For example, in the vertical 
position, ICP baseline level is negative with a mean of around -10 mm Hg, but not exceeding -
15 mm Hg.21 Although tolerable, persistently elevated ICP levels of 15-22 mm Hg are 
considered hypertensive and are indicative of an underlying pathology requiring treatment.16 
Aggressive therapy is typically initiated when ICPs surpass 22 mm Hg.17,22 These pressures are 
characteristic of impaired autoregulatory capacity and if present for sustained periods of time 
(>37 min in adults and >8 min in children23), may be predictive of poor patient outcomes in 
regards to survival rates and a long-term functionality.17 Moreover, the modeled relationship 
between elongated periods of high ICPs and poor outcomes was found to be nearly exponential 
in both the adult and pediatric populations.23 ICP levels exceeding 40 mm Hg are characteristic 
of acute brain injuries and cannot be tolerated for extended durations (>30 min).16,24 It should be 
noted that reported ICP thresholds are even lower for special populations such as the pediatric, 
elderly, and female populations.23,25 One of the major factors associated with adverse events of 
elevated ICP and its duration is the cerebral perfusion flow, critical decrease of which can cause 
secondary ischemic injury.16 Cerebral perfusion flow is regulated by the cerebral perfusion 
pressure (CPP) defined by the difference between mean arterial pressure and ICP.26,27 The 
current guidelines recommend maintaining CPP between 60 and 70 mm Hg.22 This approach 
aims to prevent secondary injuries due to hypoperfusion (e.g., cerebral ischemia) or 
hyperperfusion (e.g., edema).16 Increased ICP levels also adversely impact the brainstem 
function as excessive pressures can cause bradycardia and hypertension (Cushing reflex), and 
if left untreated, precipitate respiratory depression and death.28  
 
Hypothetically, the extent of adversity to large-volume IT injections/infusions should depend not 
only on the magnitude of the CSF pressure elevation but also the duration of such increases. 
This fact implies that both the volume and the delivery rate of liquids added to the CSF 
contribute to the safety thresholds provided that the relationship between these factors and the 
CSF pressure is established. These thresholds, least the physiological mechanisms underlying 
them, have not been studied systematically with respect to IT administrations, in neither humans 
nor laboratory animals. 
 
Considering prior advances in ICP research obtained primarily from trauma patients, this study 
aims to establish a method of ICP monitoring for characterizing disbalances in the CSF 
pressure caused by various modes of IT administrations. The safety thresholds are estimated 
and analyzed across species to provide recommendations for translational studies aiming at 
developing clinical approaches for monitoring the safety of IT therapy delivery. To this end, we 
carried out experiments in rats and NHPs and: (1) determined the relationship between ICP, 
injection rates and volumes, (2) characterized the safety thresholds for ICP elevations, and (3) 
investigated the patterns of ICP relaxation to the baseline levels after bolus injections. The 
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obtained data are discussed within the context of current knowledge on the involved 
physiological mechanisms and translational implications. 
 
MATERIALS AND METHODS 
 
Animals 
 
All animal studies were carried out in accordance with the protocols approved by the 
Institutional Animal Care and Use Committee of Massachusetts General Hospital. Male 
Sprague-Dawley CD rats (n=8, 325±76 g) were obtained from Charles River Laboratories 
(Shrewsbury, MA). One cynomolgus (Macaca Fascicularis, 7.5 kg) and one rhesus monkey 
(Macaca Mulatta, 8.2 kg) were obtained from Northern Biomedical and were equipped with 
subcutaneous injection ports (P.A.S. Port Elite, Smiths Medical ASD, Inc.). The ports were 
connected to polyurethane kink-resistant catheters (Smiths Medical ASD, Inc.) entering the 
subarachnoid space at the L4/L5 spinal segment and were advanced to the L1/T12 area. Both 
ports were surgically implanted more than 3 months prior to the study and maintained as 
recommended per the manufacturer. Catheter potency and absence of leaks were confirmed by 
PET imaging with macromolecular tracers labeled with 89Zr, as in our previous studies.5,6,7 By 
the time of these studies, the ports had one-way (inwards) potency, likely due to the 
development of tissue flaps around the catheter openings. All animals were kept on a 12 
hours/12 hours light/dark cycle, switching on at 7 AM and off at 7 PM. Food and water were 
provided ad libitum to rats. Monkeys had three meals a day while the water was provided ad 
libitum. 
 
ICP registration methodology 
 
ICP in rats was measured directly in the cisterna magna pool of the CSF using a 1F 
piezoresistive diffused semiconductor pressure sensor mounted on the tip of a 20 cm long 0.8 F 
polyimide catheter (Millar, Inc). The pressure catheter was inserted through a temporary 
angiocatheter installed through the atlanto-occipital membrane. In monkeys, port configuration 
did not allow sensor insertion into the leptomeningeal space. The pressure (ICPL) was 
measured externally, using the same sensor inserted into a saline-filled catheter line connected 
to the subcutaneous IT port. Electrical signals from the sensor were processed using a FE221 
Bridge Amplifier (ADInstruments) coupled with a PowerLab 4/35 data acquisition platform 
(ADInstruments). Control of both modules, signal acquisition, and subsequent ICP waveform 
analysis were performed using a LabChart 8 software (ADInstruments) installed on an Apple 
MacBook Pro laptop. ICP sampling rate was set to 1000 measurements per second. Prior to all 
ICP measurements, the pressure transducer was soaked in sterile water or saline at room 
temperature for at least 30 min. After that, atmospheric pressure was set to 0 mm Hg and the 
stability of the sensor signal was ensured by recording the baseline for at least 10 min.  
 
Rats 
 
Cisterna magna catheterization 
 
Percutaneous non-surgical catheterization of the cisterna magna was carried out following the 
technique developed by Jeffers and Griffith.29 Animals were anesthetized by inhalation of 
isoflurane/air mixture (3% for induction, 2% for maintenance) given at 300 ml/min flow rate using 
a SomnoSuite® small animal anesthesia platform (Kent Scientific). The animal was then 
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mounted on a stand inclined to 50° angle with the head flexed down, thereby positioning the 
occipital bone in the horizontal plane. The back of the neck and the base of the skull were 
shaved and disinfected with 70% ethyl alcohol. The location of the cisterna magna was 
identified by palpation of a 3-mm2 rhomboid depressed area (atlanto-occipital joint) in the middle 
of the line connecting the ear bases. A 24G 0.75” IV catheter (Angiocath™, Becton Dickinson) 
was then slowly inserted to a depth of 7 mm. The inner needle was immediately removed after 
the appearance of the clear CSF in the outer catheter. The catheter’s Luer adapter was then 
promptly capped, and the catheter was affixed to the skin with a cyanoacrylate gel. Localization 
of the tip of the (radiopaque) catheter in the cisterna magna was verified at the end of the study 
by taking a CT scan of a rat’s head (Fig. S1A). 
 
ICP measurements 
 
ICP measurements in rats were carried out using the equipment configuration shown in Fig. 
S1B. Specifically, after the cisterna magna catheterization, a Tuohy Borst adapter (Cook 
Medical) equipped with a side arm (initially closed) and pre-filled with saline was connected to 
the IV catheter via a Luer adapter. A micro-tip pressure transducer was then slowly advanced 
into cisterna magna through the entire length of the Tuohy Borst adapter and the IV catheter. 
The adaptor was tightened up, and the baseline ICP referenced to the atmospheric pressure 
(pre-set to 0 mm Hg) was recorded for 5-15 min. One of the following procedures was 
subsequently performed. 
 
ICP setting 
 
A 60” extension set polyvinyl chloride minibore tubing (Acacia) connected to a bottle of sterile 
saline and subsequently primed was attached to the Tuohy Borst’s side arm. ICP registration 
started immediately after opening the side arm. Initially, the saline surface meniscus was 
leveled with the cisterna magna thereby equilibrating ICP with the ambient atmospheric 
pressure. ICPs of 1.0±0.4, 5.5±1.1, 8.3±2.5, 12.3±0.7, 17.6±1.2, 21.1±2.7, 24.7±3.8, 30.1±5.1, 
and 37.0±2.3 mm Hg were then set in each of the 4 rats by positioning the saline bottle at 
progressively increasing heights. At each height, ICP was recorded for 10-15 min. 
 
CSF drainage assessment 
 
A sterile saline bag was suspended on a bench-top pole and attached to a dripper. The dripper 
was a manually-made device for the flow rate measurement. It consisted of a conical plastic tip 
hermetically inserted inside the air-filled plastic cylinder. The outside end of the tip was used for 
the attachment to the saline bag. The opposite end of the cylinder was connected to the saline 
line leading to the side arm of the Tuohy Borst adapter. When the saline flow was activated by 
placing a saline bag at different heights, the dripper produced drops of calibrated size (12.8±0.2 
ml), the number of which was visually counted using a timer thereby enabling a flow rate 
calculation. ICP fluctuations caused by falling drops (Fig. 2A) provided an additional method for 
the dripping rate measurement. Changes to the saline column’s heights caused respective 
changes in the ICP baseline from 0 to 50 mm Hg, which were measured using the ICP 
registration methodology. For each ICP level, continuous recording was performed for 10-15 
min. Experiments were repeated in 4 rats weighing 443±104 g. 
 
IT infusions with a pump 
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A Silastic™ silicone tubing (Dow Corning, 0.76 mm inner diameter, 1.65 mm outer diameter), 
primed and connected to a 1 ml syringe (Becton Dickinson) filled with saline and mounted on a 
pressure pump (Model 22, Harvard Apparatus), was attached to the Tuohy Borst’s side arm. 
ICP recording was activated immediately with the opening of the side arm and the start of the 
infusion of 200-240 μl of saline at one of the following rates: 10, 20, 40, 80, and 120 μl/min. 
Each rate was tested in three different rats. Each of 4 rats was used for 3-4 serial tests allowing 
sufficient time between infusions as confirmed by the ICP relaxation to the baseline level. 
 
Manual bolus IT injections 
 
An infusion plug (Argyle™, Covidien) equipped with a rubber septum was attached to the Tuohy 
Borst’s side arm. A 1-ml tuberculin syringe (Becton Dickinson) filled with saline was inserted in 
the plug and the injection of a tested volume was performed at 2.7±0.9 ml/min. This is the rate 
that was typically used in our previous studies utilizing manual cisterna magna injections. The 
syringe was withdrawn at the end of the injection, and the ICP was allowed to return to the 
baseline level. The syringe was reloaded, and the injection of the next volume was repeated. 
The following volumes were tested: 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, 0.35, 0.45,0.6, 0.8, 1.0, and 
1.5 ml. For the injection of 1.5 ml of saline, a 3 ml syringe equipped with a 23G needle (Becton 
Dickinson) was used. A temperature-controlled thermal pad or a heating lamp maintained body 
temperature over the entire duration of the procedures (ca. 2 h). At the end of each study, a rat 
was euthanized by way of cardiac infusion of Euthasol (pentobarbital, 100 mg/kg). 
 
Monkeys 
 
Sedation and preparation 
 
Animals were fasted for 12 h before the experiment. Atropine sulfate (0.03 mg/kg) was 
administered IM 1 h before the study to decrease saliva production. 10 min thereafter, the 
animal was sedated with Ketamine (15 mg/kg)/Xylazine (1 mg/kg) IM at the animal facility and 
transported to the laboratory. The animal was intubated with a 3 mm (Æ) endotracheal tube 
(Mallinckrodt™, Covidien), and the tube was connected to the anesthesia line providing 
continuous 2% isoflurane/O2 flow at 2 l/min. Heart and respiration rates, blood oxygen saturation 
(SpO2), end-tidal CO2 content, and rectal temperature were monitored continuously and 
documented every 15 min. Isoflurane content and flow rate were adjusted upon need to 
maintain physiological vitals. The anesthetized animal was placed on a soft pad in a prone 
position. Supplemental heat was provided via a blanket filled with circulating warm water. 
 
IT injections and ICP measurements 
 
ICP measurements in monkeys were carried out using the equipment configuration shown in 
Fig. S2. The skin above the IT port was shaved and wiped with 70% isopropanol and treated 
with Betadine. A saline-primed Huber needle (Access Technologies), attached to the t-
connector (Microbore extension set – 5 inch, Hospira) with a clamped catheter, was inserted 
into the port. The catheter was then attached to the saline-primed side-armed Tuohy Borst 
adapter (Cook Medical). 1F micro-tip pressure catheter (Millar, Inc) was inserted inside the 
adapter, down to the Y-junction, and leveled with the surface of the animal’s spine. The Tuohy 
Borst’s side arm was then opened to equilibrate the line pressure with the ambient atmospheric 
pressure. Once a stable pressure line was recorded for at least 10 min, the Tuohy Borst’s side 
arm was closed and the connection with the t-connector was opened enabling indirect in-line 
ICP (ICPL) recording. Baseline registration was carried out for at least 10-15 min. Continuous 
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ICP monitoring was then performed during the IT administration of one 5 ml saline bolus in the 
rhesus monkey and five 1 ml saline boluses, 2.5 min apart or two 3 ml saline boluses, 8 min 
apart, in the cynomolgus monkey. To emulate the conventionally used procedure, trained 
personnel performed all IT infusions in monkeys manually. Infusion rates were determined by 
calculating the ratio of the duration of steady advancement of the syringe plunger to the 
administered volume. Upon the study completion, anesthesia was gradually withdrawn and the 
animal was returned to the housing facility.  
 
Measurement of hydrostatic resistance in the injection port (in vitro) 
 
The same pressure measurement set-up as in the in vivo study with monkeys was utilized. A 
23G needle (Becton Dickinson) attached to the 60” extension set polyvinyl chloride minibore 
tubing (Acacia) was inserted into the t-connector. The other side of the tubing was attached to 
the 10ml syringe (Becton Dickinson) filled with saline and mounted on a pressure pump (Model 
22, Harvard Apparatus). All lumens were primed with saline prior to pressure measurements. 
Infusion at one of the tested rates was initiated and lasted for 107.8±37.3 s until the steady state 
pressure was established and recorded for 101.0±37.2 s. When the infusion was completed, the 
pressure was allowed to return to the baseline level. 102.0±42.5 s after the steady baseline 
recording, infusion at the next rate was performed. The following infusion rates were tested: 
0.01, 0.05, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, 6.0, 6.5, 7.0,7.5, 
and 8.0 ml/min. 
 
Post-acquisition ICP data processing 
 
Post-acquisition data processing was performed using LabChart 8 software (ADInstruments). 
Mean ICP was determined by averaging a pressure pulse wave over 4±1 min (1478±387 
pulses). ICP amplitude is defined as the amplitude of the fundamental (P1) component of the 
ICP pulse wave. To determine it, fast Fourier transform (FFT) of the ICP time block used for the 
mean ICP calculation was performed using the following parameters: FFT size: 1000 or 2000 
points, data window type: Welch, window overlap: 93.75%. Spectrally resolved P1 harmonic 
was identified in the frequency range of 3.9-8.8 Hz. ICP relaxation time characterized elasticity 
of the anatomical components of intrathecal compliance and was measured as a time required 
for ICP to decrease by 90% from the peak value. Data fitting was performed by a least squares 
method using a Microsoft Excel 2013 program (linear fitting) or the ZunZun online computational 
resource (www.zunzun.com) (sigmoidal and bi-exponential fitting). 
 
RESULTS 
 
Adaptability of rats to the increased ICP 
 
An IT administration normally results in ICP elevations due to the increased volume in the 
subarachnoid space. Therefore, it was important to investigate how different ICP elevations are 
tolerated in order to determine safe regimes of IT infusions. To this end, we induced in rats 
(n=4) progressively increased CSF pressures and monitored the changes in the key ICP 
parameters: mean ICP, ICP amplitude, and spectral characteristics (frequencies and 
amplitudes) of the ICP waveform’s major components (harmonics). 
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Figure 1. Characteristics of ICP elevation in a rat. (A) Various ICPs induced by a saline column 
attached to the rat’s CSF in the cisterna magna. Shaded area indicates baseline ICP. A representative 
ICP pulse waveform at low and high pressures are shown in the left and right sides, respectively. P1, P2, 
and P3 are the major pulse’s harmonics. (B) The amplitude-frequency characteristics of the spectrally 
resolved P1, P2, and P3 harmonics of the baseline ICP pulses (shaded area in Fig. 1A). A result of 
averaging of 2564 FFTs each consisting of 2000 points. (C) Spectrum view of the changes in the 
harmonics’ frequencies and amplitudes as a result of ICP elevation over time (Fig. 1A). (D) ICP 
autoregulatory capacity and compensatory reserve in rats. Three specific zones characterizing different 
states of ICP compensatory reserve are shown and are based on the correlation between the mean 
amplitude of the P1 component of the ICP pulse and the mean ICP. Each data point represents a mean 
value obtained by averaging over 4 animals. Error bars indicate standard deviations. 
 
Fig. 1 A-C show a representative ICP monitoring experiment in a rat undergoing a progressive 
ICP elevation. Baseline ICP (Fig. 1A, shaded area) averaging 8.6±1.7 mm Hg (across all 
studies) was characterized by periodic pulses, a waveform of which had a classical shape (Fig. 
1A, left waveform) with spectrally resolved P1, P2, and P3 components (Fig. 1B). ICP elevations 
caused waveform distortion (Fig. 1A, right waveform) reflecting the changes in the spectral 
characteristics (frequency and amplitude) of the harmonics as shown in Fig. 1C. Specifically, the 
harmonics’ frequencies and amplitudes, as well as the distance between harmonics increased 
with ICP elevation, with the most dramatic change affecting the amplitude (5.2±1.5 – fold 
increase). All the changes became rapidly pronounced after the pressure reached 18 mm Hg, 
before which only a minor yet consistent increase was observed. Spiking artifacts in the 
waveforms, which became pronounced at ICP > 20 mm Hg (Fig. 1A), were caused by the 
increased neck motion of the rats due to the increased respiration rate (visual observations). 
 
The adaptability of rats to the increased ICP (autoregulatory capacity) was characterized by the 
relationship between the time-averaged amplitude of the P1 component and the mean ICP (Fig. 
1D). This relationship has been shown to be a function of the capacity of the compensatory 
mechanisms to maintain the physiologically relevant pressures in response to different 
perturbations in the CSF volume16,17,18. Correlation between these two variables formed three 
specific zones characterized by: (1) low synchronization (good compensatory reserve) at low 
ICPs (1-18 mm Hg), (2) high synchronization (poor compensatory reserve) at higher ICPs (18-
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28 mm Hg), and (3) negative correlation (impaired compensatory mechanisms) at ICPs > 28±4 
mm Hg (“critical pressure”). All rats that experienced ICPs higher than the critical pressure for 
prolonged time (>10 min) experienced a fatal outcome. 
 
Performance of the CSF drainage system under pressure 
 
CSF drainage into blood plays a vital role in the accommodation of volumes added to the CSF 
and in adaptation to elevated ICP due to the pressure-valve function of the drainage sites. The 
vast majority of these sites are located at the CSF-blood interface in the arachnoid protrusions 
(arachnoid villi) into the venous sinuses within the cranial (superior sagittal and transverse 
venous sinuses) and spinal (venous sinuses near dorsal root ganglia) compartments30,31. To 
assess the capacity of these sites under different ICPs, we developed a novel method to 
measure the CSF drainage rate schematically depicted in Fig. 2A. Briefly, it leverages the 
measurement of the saline intake in a fluid line connected to the CSF pool, which is challenged 
by different pressures using a water column effect. Fig. 2B illustrates the obtained ICP 
dependency of the CSF drainage rate for individual rats (n=4). The dependency has a gross 
exponential shape with a good linearity in the beginning (6-23 mm Hg). A reciprocal to the 
linearity coefficient denotes the outflow resistance (0.30 mm Hg/(μl/min)) characterizing the 
drainage performance. Deviations from linearity in the form of lower ICP than expected at ICP > 
23±1 mm Hg were consistent with the respective region of weak compensatory mechanisms (18 
mm Hg < ICP > 28 mm Hg) shown in Fig. 1D. Non-linearity can be explained by altered flow 
characteristics due to either the change in the capacity of the normal CSF drainage sites or the 
emergence of additional outflow pathways. Maximally tolerated pressures (MTP) marked with 
black asterisks averaged 30±3 mm Hg correlating with the region of impaired compensatory 
mechanisms (ICP > 28 mm Hg) shown in Fig. 1D. The following reduction of the drainage rate 
at ICP > MTP is likely indicative of the discontinuation of some drainage pathways due to death. 
 
 
 
Figure 2. Viability of the CSF drainage system under pressure. (A) A sketch of the originally-
developed experimental setup for measuring the rate of unconstrained CSF drainage at different ICPs. 
Components of the setup: (I) bench-top pole with a suspended saline bag set at different heights, (II) 
dripper with calibrated drop size attached to the saline bag and connected to the saline line, (III) Tuohy 
Borst adapter attached to the catheter inserted in the cisterna magna; saline line connected to the 
adapter’s side arm, (IV) micro-tip pressure sensor advanced to the cisterna magna through the adapter 
and catheter, (V) data acquisition platform, (VI) control and data analysis console (note the ICP 
fluctuations on the computer screen caused by falling drops), (VII) small-animal isoflurane anesthesia 
platform. (B) ICP dependency of the CSF drainage rate. MTP: maximally tolerated pressure. Black 
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asterisks mark MTP for each rat. Data points in the 6-23 mm Hg region were used to build a linear 
regression (parameters are shown).  
 
Pump slow-rate IT infusions in rats 
 
Once the critical pressure, above which adaptation to the increased ICP is impaired, was 
determined, it was used to determine and characterize safe regimes of IT administrations. To 
this end, we employed a continuous infusion method when the rats (n=4) were infused 200-240 
μl of saline (ca. 100% of the total CSF volume in rats) at different rates while the ICP response 
was continuously monitored. The obtained data demonstrated that the shape of the ICP buildup 
is irrelevant of the infusion rate in the tested interval of slow rates (10-120 μl/min) (Fig. 3A). All 
rates led to the to the ICP stabilization. However, despite different plateau levels, ICP steady 
state occurred at the same infused volume of 150 μl. The relationship of the plateau ICP with 
the infusion rate (Fig. 3B) showed a good linearity up to 23.5 mm Hg (40 μl/min), with the 
linearity coefficient (0.35 mm Hg/(μl/min)) denoting the outflow resistance. It should be noted 
that both the ranges of the linear response of the CSF drainage system and the values of the 
CSF outflow resistance obtained by this and the dripping method (Fig. 2B) showed significant 
correlation thereby validating the latter. Infusion rates higher than 40 μl/min caused significant 
deviations from linearity in Fig. 3B in the form of lower steady-state ICP than expected. As such, 
collectively with the data shown in Fig. 2B, 40 μl/min can be considered as the threshold below 
which infusions are primarily compensated by the fluid outflow through mesothelial pores in 
arachnoid villi (granulations). The mechanistic basis of the additional drainage system activating 
at higher rates (and ICP) is to be determined. 
 
Accommodation of liquids added to the CSF at rates > 40 μl/min and ICP autoregulation at 
pressures > 24 mm Hg appear to be based on a combination of compensatory mechanisms that 
can be combined in two groups: pressure-dependent CSF drainage and intrathecal compliance. 
Assessments of their respective involvement can be obtained by analyzing the relaxation of the 
progressively elevated ICP to the baseline level. For example, 40, 80, and 120 μl/min infusions 
of 120 μl of saline caused rapid ICP increases above 20 mm Hg followed by the repeated 
patterns of a multi-phase relaxation process (Fig. 3C). Among two or three relaxation phases, 
the first and the fastest phase (phase I) had an increasing contribution with the pressure 
increase. This is likely the result of the action of the mechanisms of intrathecal compliance due 
to the significantly limited elasticity capacity of the anatomical correlates (not presently clearly 
established). Analysis of the dependency of the relaxation time on the ICP elevation magnitude 
(Fig. 3D) obtained for all studies revealed a linear region followed by stabilization at 17.4±0.1 
min. The bend point at 12 mm Hg (20.6 mm Hg of the total ICP) corresponding to the infusion 
rate of 30 mm Hg is likely another indication of the transition from one (mesothelial drainage-
based) to two (or more) primary mechanisms involved in the accommodation of liquids added to 
the CSF at raising infusion rates. In fact, all infusions that caused ICP elevations above 12 mm 
Hg were followed by multi-phase relaxations. 
 
ICP waveform and frequency analyses of the ICP curve in the representative example given 
above (Fig. 3C) revealed the presence of P1, P2, and P3 harmonics that remained at their 
characteristic frequencies (5.4, 10.3, and 15.6 Hz, respectively) (Fig. 3F) during ICP elevation 
and relaxation phases (Fig. 3E). This observation contrasts with constant-pressure studies (Fig. 
1C), which is likely to be explained by the shorter infusion time (1-3 min) seen in the latter case, 
which was presumably insufficient to increase the heart rate in response to the elevated ICP. 
The harmonics’ amplitudes, in contrast, promptly increased with each ICP elevation (Fig. 3E, 
color transitions from green to red) suggesting the robust impact of these infusions on the 
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compliance-based compensatory reserve, which agrees with our findings shown in Fig. 1D 
(poor compensatory reserve region). 
 
Time-dependency of the response of different physiological components to elevated ICP turned 
out to play a critical role in the safety of high-volume intrathecal boluses as follows below. 
 
 
 
Figure 3. ICP response to IT infusions. (A) ICP – IT infused volume relationship for different infusion 
rates. “Critical pressure” (28±4 mmHg) denotes the ICP above which pressure compensatory 
mechanisms were found to be impaired (Fig. 1D). (B) Relation of the approximated plateau ICPs with the 
infusion rates. Parameters of the linear regression for infusion rates in the interval of 10 – 40 μl/min are 
shown. Error bars represent standard errors obtained by averaging the data points in Fig. 1A at the 
steady state (> 150 μl of the infused volume). (C) A representative picture of the ICP response to the 
infusion of the same volume (120 μl) at three different rates - 40, 80, and 120 μl/min. The shaded area is 
the baseline ICP. A representative ICP waveform is shown in the bottom. (D) Relationship between the 
time of relaxation to the baseline ICP and the magnitude of ICP elevation. Non-averaged data points of 
individual experiments are shown. Parameters of the linear regression are given for 10 – 40 μl/min 
infusion rates. (E) A representative picture of the harmonic analysis of the shaded area in Fig. 3C. A 
result of averaging of 1158 FFTs each consisting of 2000 points. P1, P2, and P3 harmonics were 
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spectrally resolved at all pressures. (F) Spectrum view of changes in the harmonics’ frequencies and 
amplitudes as a result of IT infusions. 
 
Manual bolus IT injections in rats 
 
Sequential injections of saline volumes ranging from 0.05 to 1.5 ml at the average rate of 
2.7±0.9 ml/min in the cisterna magna of a rat resulted in the prompt ICP elevations (Fig. 4A). 
The dependence of the magnitude of those elevations on the injected volume had a logarithmic 
shape (Fig. 4B). ICP stabilized at ca. 200 mm Hg level, which was found to be the maximally-
tolerable suggesting the capacity limit of the relevant adaptation mechanisms. ICP relaxations to 
the baseline level (Fig. S3) were of bi-exponential shape as evidenced by moving frame 
linearizations (Guggenheim method32) having a bi-linear shape (Fig. S4). Bi-exponentiality 
reflects the involvement of fast and slow relaxing components characterized by large and small 
time constants. Relative fractions of both components as a function of the ICP elevation 
magnitude are shown in Fig. S9A revealing the diminished contribution of the slow relaxation 
processes as the ICP increased. It is of note that the relationship of the total relaxation time 
(ranging from 9 to 172 s) with the ICP elevation magnitude had a bi-exponential form whereas 
the same relationship of the total elevation time (2-20 s) was linear (Fig. 4C). Neither ICP 
elevations nor relaxations were associated with significant changes to the heart or respiratory 
rates (Table S1). 
 
 
 
Figure 4. Bolus IT injections in rats. (A) The time-dependence curve of ICP elevation. The average 
administration rate is 2.7±0.9 ml/min. (B) Dependence of the ICP elevation on the injected volume. (C) 
The pressure dependence of the total ICP elevation (blue) and ICP relaxation time (red). 
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Large-volume manual IT administrations in ported monkeys 
 
From the translational perspective it was important to ascertain if the ICP effects observed in 
rats are similar to those in monkeys. The impact of large-volume (with respect to the total CSF 
volume) IT infusions on the ICP in monkeys was assessed by monitoring the ICPL in the saline-
filled catheter attached to the IT port during and after manual bolus administrations of 1, 3, and 
5 ml (ca. 5-25% of the CSF volume) of saline (Fig. 5, A-C). All injections caused the initial ICPL 
elevation from the baseline level of 2.2±0.7 mm Hg to 85-200 mm Hg. Once each injection was 
completed and a needle was withdrawn, ICPL quickly decreased to 30-60 mm Hg followed by a 
subsequent significantly slower relaxation to the initial baseline ICPL accompanied by pressure 
pulsations. Such a complex ICPL’s behavior can be explained by the fact that ICPL is made up 
by two components – the endogenous CSF pressure and hydrodynamic resistance pressure in 
the injection system. The latter component can be deteriorated by the partial catheter 
compression due to the tissue build-up around the catheter over time. However, the bottom 
estimate of the dependence of the resistance pressure on the infusion rate was obtained in the 
in vitro study using the same port and ICPL measurement method (Fig. 5D). The best linear fit 
was found for the 0-7 ml/min interval of injection rates. Time dependence of the ICPL during 
infusion (Fig. S5, A) at each tested rate from 0.01 to 8 ml/min demonstrates quick (2-13s) 
establishment of the steady-state pressures characterizing hydrodynamic resistance. Relaxation 
to the baseline ICP after the infusion completion was somewhat slower and ranged from 8s to 
21s. Both elevation and relaxation durations were found to be a linear function of the infusion 
flow rate (Fig. S5, B). 
 
Characterization of the infusion resistance pressure in the port allowed discrimination of the real 
pressure in the CSF. ICP dependence on the infused volume for the studied infusion rates is 
shown in Fig. 5E. Infusions with rates up to 2 ml/min revealed the tendency to lead to steady-
state pressures, which were found to linearly depend on the infusion rates (Fig. 5F), as in the rat 
studies. Over the entire duration of the procedures, the monkey’s vital parameters (heart and 
respiration rate, SpO2, CO2 content in the exhaled air, and rectal temperature) were constantly 
monitored. Respiration and cardiac complications (elevations of both rates followed by apnea) 
became apparent at pressures exceeding 50 mm Hg. Due to this safety limit, we were not able 
to formally characterize administrations of volumes higher than 1 mL for high-rate infusions (3.4-
7.8 ml/min, Fig. 5A and E). 
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Figure 5. Large-volume bolus IT injections in monkeys. Time-dependence of the ICP measured in-
line (ICPL) for a series of 1 ml bolus injections in the cynomolgus monkey with the average infusion rate of 
5.3±1.8 ml/min (A), a series of 3 ml infusions in the cynomolgus monkey with the average infusion rate of 
1.9±0.6 ml/min (B), and a 5 ml bolus injection in the rhesus monkey with the infusion rate of 1.8 ml/min 
(C). (D) Relation of the IT injection port’s ICPL with the injection rate. (E) Dependence of the CSF 
pressure (ICPCSF) on the infused volume for different infusion rates. The ICPCSF was derived by 
subtracting the resistance pressure in the port. (F) Relation of the approximated steady-state ICPs with 
the infusion rates. Parameters of the linear regression are shown. Error bars in (E) and (F) represent 
standard deviations. 
 
As in the rat studies, the pressure relaxation kinetics in NHPs was found to be best fit by a bi-
exponential curve (Fig. S6) as suggested by the bi-linear shape of the Guggenheim linearization 
(Fig. S7). Bi-exponentiality reflects the involvement of fast and slow relaxing components 
characterized by large and small time constants. Relative fractions of both components as a 
function of the ICP elevation magnitude are shown in Fig. S9B revealing the diminished 
contribution of the slow relaxation processes as the ICP increased. The total time of ICP 
relaxation from the peak value to the baseline level averaged 5.0±0.6 min without a noticeable 
correlation with the ICP elevation magnitude. 
 
DISCUSSION 
 
This study was aimed at estimating the safety thresholds for IT infusions in rats and monkeys 
based on ICP-derived indices. In the first set of studies in rats, the animals were subjected to 
gradually increasing pressures applied within the CSF while measuring major ICP waveform 
characteristics, such as a mean ICP and a pulse amplitude of the fundamental component (P1, 
percussion wave). Analysis of the relationship between these two characteristics is frequently 
used for the assessment of the ICP autoregulatory capacity and the compensatory 
reserve16,17,33. These concepts characterize the physiological mechanisms of adaptation to the 
increased ICP. Exhaust of these resources is typically associated with irreversible changes due 
to the high pressures and leads to poor outcomes16,17.  
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Published analytical34 and experimental19 data demonstrate a linear relationship between the 
ICP pulse amplitude and the mean ICP. Additionally, detailed analysis of the sigmoid form of the 
ICP-CSF volume curve suggests three different degrees of linearity specific for three different 
ICP zones17,19,33. The first zone, situated at low pressures, is characterized by low 
synchronization between changes in amplitude and a mean ICP, indicating a good 
compensatory reserve used to accommodate volume alterations occurring as a result of 
cerebral blood pulsations. In the middle zone, this synchronization is more pronounced and 
therefore the pulse amplitude increases more readily with the raised ICP. This denotes a poor 
compensatory reserve, implying that even small volume augmentations can become 
uncompensated trending toward rapid ICP elevations that can become dangerous in nature. 
Negative correlation at high ICPs denotes detrimental, irreversible changes in the compensatory 
mechanisms leading to permanent structural damages or death. 
 
Our rat data (Fig. 1D) is consistent with the described amplitude-pressure paradigm showing a 
relatively broad (18 mm Hg) area of low synchronization and similar middle and third zones (ca. 
10 mm Hg-wide each). By combining the first and second zones, one can derive the working 
range of safe ICPs for performing IT administrations. This relatively wide range spans from the 
baseline level of 8.6±1.7 mm Hg through the critical ICP of 27.5±3.8 mm Hg. Animals that 
underwent pressures higher than the critical ICP for prolonged periods of time (10-15 min) 
experienced a fatal outcome likely associated with cardiac complications. In fact, during ICP 
elevation we observed a progressive shift of the fundamental (P1) component of the ICP pulse 
wave to higher frequencies (from 5.4 Hz to 8.3 Hz) (Fig. 1C) indicating an increased heart rate 
(Fig. S8).  
 
The baseline and “critical” ICP values obtained in this study are also in good agreement with the 
published data, which specify a relatively wide range of pressures with respect to species, 
measurement method, posture, and health condition. For example, the values of the resting 
CSF pressure reported for the prone position span from 3 to 8 mm Hg in anesthetized adult rats 
(cisterna magna measurements)35.36,37, from 7 mm Hg to 14 mm Hg in non-anesthetized 
monkeys (cisterna magna measurements)38, and in non-anesthetized humans from 7 mm Hg to 
15 mm Hg (lumbar measurements)20. As a criterion of tolerance for elevated ICPs, it was 
proposed39 to use a linearity of the plateau ICP-infusion rate relationship derived from a 
constant-rate infusion experiment. It was suggested39 that deviations from linearity at high rates, 
in the form of lower plateau ICP than expected (decrease in the CSF outflow resistance) could 
be indicative of altered flow characteristics of the CSF outflow sites. Most of these sites are 
located on the CSF-blood interface in the arachnoid protrusions (arachnoid villi) within the 
venous sinuses in the cranial (superior sagittal and transverse venous sinuses) and spinal 
(venous sinuses near dorsal root ganglia) compartments30,31. At high flow rates, unidirectional 
and CSF pressure-dependent31 flow through arachnoid villi can reach intrinsic capacity thereby 
hypothetically increasing the risk of structural damages to the drainage components. For 
instance, ultrastructural changes in the arachnoid villi of adult rats have been reported for CSF 
pressures above 22 mm Hg40. A linear plateau pressure response to constant-rate infusions 
with maximal ICP ranges from 15 to 30 mm Hg, has been found for a number of adult animals 
(mice41, rats39, cats42, rabbits43, monkeys44) and man20,45,46. A non-linear response has even 
been observed in rats at low infusion rates (<34 μl/min) although the plateau ICP ranged from 
29 mm Hg to 81 mm Hg in that study35. At rates higher than 34 μl/min, equilibrium pressures 
were not consistently obtained, and electroencephalographic patterns began to reflect the 
disturbed cerebral function. Therefore, acquisition of steady-state pressures became a widely-
accepted criterion of physiologically safe adaptation to the slowly infused liquids regardless of 
the shape of ICP-infusion rate relationship. No such criterion was documented for bolus 
injections however. 
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Considering that a constant-rate infusion method is associated with forced perfusions through 
the LMS, which could hypothetically be damaging per se at high rates, we developed the 
alternative method, which harnessed a direct measurement of the rate of unconstrained, free 
drainage at varying ICP values (Fig. 2). The obtained gross exponential form of the drainage 
rate-ICP relationship suggests a high throughput of the CSF drainage system, which 
hypothetically consists of several contributary factors activating at different pressures. A good 
linear regression obtained until the ICP of 23±1 mm Hg can be attributed to drainage through 
the arachnoid villi based on the previously reported data39 and correlation with our findings in 
the constant-rate infusion study (Fig. 3B). However, further deviations from linearity occurring 
from 23±1 mm Hg to 30±3 mm Hg (MTP) in Fig. 2B and similarly from 23.5 mm Hg to 28.8 mm 
Hg (critical pressure) in Fig. 3B are likely explained by the emergence of additional, extra-
villious drainage pathways rather than previously suggested pressure-related ultrastructural 
damages to arachnoid villi40. In fact, deviations from linearity were still characterized by the 
steady state ICP condition at the respective pressures (Fig. 3A), which is suggestive of 
physiologically normal functionality of the underlying mechanisms. Furthermore, the ICP 
relaxation process repeatedly returned the elevated ICP to its baseline value (Fig. 3C), albeit at 
faster rates (Fig. 3D), which would not have been the case if any damages had occured. 
Additionally, it should be noted that the entire interval of tolerated pressures (6-30 mm Hg) in 
Fig. 2B correlates with the range of unimpaired compensatory mechanisms (9-28 mm Hg) in the 
constant pressure study (Fig. 1D). Lethality at pressures averaging 30±3 mm Hg occurred only 
after prolonged (>10 min) exposures and is likely explained by extended, non-elastic (as 
suggested by negative correlation in the respective ICP region on Fig. 1D) compressions of vital 
CNS or vascular components (requires further investigation). The following reduction of the 
drainage rate at ICP > MTP is likely indicative of the discontinuation of some drainage pathways 
due to death. 
 
The exact mechanisms of the CSF drainage through the mesothelial layer of arachnoid villi are 
insufficiently elucidated due to significant methodological difficulties. The working hypotheses 
include an active vesicular transport47 such as a fluid-phase caveolae-mediated 
macropinocytosis48,49 and filtration through either permanent or dynamic mesothelial pores 
formed by merged vacuoles50. A recent study of the pressure relief mechanisms in the 
endolymphatic sac of the inner ear51 adds the theoretical possibility of a similar passively 
working pressure valve in the mesothelial layer of arachnoid villi. In the inner ear, the valve is 
formed by the dynamic overlapping basal lamellae of adjacent endothelial cells, the apical 
junctions of which are separated under increasing pressure thereby forming ~1 μm-wide gaps. 
The authors specifically note similarities between the ultrastructure of their lamellar barriers and 
the previously described giant vacuoles found abundantly in the pressure- and fluid traffic- 
regulating tissues, such as Schlemm’s canal of the eye52, endolymphatic sac’s epithelium of the 
inner ear53, and the mesothelial layer of arachnoid granulations50. Identification of the LMX1B 
transcription factor involved in the apical junction remodeling, a mutation of which causes 
various symptoms (e.g., glaucoma54, nephropathy55, and hearing impairment55) associated with 
impaired fluid transport and hypertension in various tissues, is also suggestive of the common 
underlying pressure regulation mechanisms. Fig. 2B might also suggest that active and passive 
drainage mechanisms work in concert in the living body. In fact, average post-mortem reduction 
of the unconstrained drainage can be explained by the dysfunction of active processes and the 
remaining functionality of the drainage components that are based solely on physical principles 
(permanent pores). Research into the relevance and relative contributions of the proposed 
mechanisms remains in high demand. 
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The role and the location of the extra-villous CSF absorption pathways remain poorly 
investigated. The most widely discussed route is the hypothesized connection between the CSF 
and the lymphatic system. CSF absorbed by the olfactory mucosa and cranial and spinal nerve 
sheaths is believed to be further drained by the lymphatic system.56 The amount of the CSF 
drained through this pathway is highly debatable, varying from negligible or little57,58 to quite 
significant (up to 50%)59,60, and appears to be species-dependent58. Whatever the fraction of 
CSF is drained at normal CSF pressure, elevated ICP can potentially increase it61. For instance, 
a study in sheep demonstrated that only 10% of cervical lymph was derived from the CSF at 
normal ICP, but as ICP increased 7-fold, 80% of cervical lymph was derived from CSF and the 
cervical flow rate increased 4-fold.62 The functional role of the lymphatic pathways in man 
remains poorly investigated, however, primate data58 suggests negligible contributions. As such, 
attention should be paid when extrapolating the pressure data between species. 
 
Overall, the obtained data is consistent with previous reports and suggests the primary role of 
CSF drainage mechanisms in adaptation to raised ICP caused by low-rate infusions. The 
resulting equilibration of the infusion rate and the pressure-dependent drainage rate prevents 
liquid and pressure buildup and enables continuous perfusion within the LMS. We found that in 
rats all infusions leading to the plateau pressures could safely be used for IT administration of at 
least 240 μl (ca. 100% of the CSF volume in rat35). Although the upper volume limit remains to 
be determined, it is likely to depend more on the compound’s cytotoxicity and 
hemoconcentration rather than volumetric limits of the LMS. This observation lays the 
groundwork for the development of the CSF dialysis technology, which has the potential to 
become a novel treatment method as noted recently63.  
 
High-rate infusions and bolus injections (2.7±0.9 ml/min in rats and 5.3±1.8 ml/min in monkeys) 
caused rapid uncompensated fluid and pressure buildup, which caused different physiological 
reactions in rats and NHPs. The upper ICP threshold for bolus injections in rats was 200 mm 
Hg, which corresponded to a bolus volume of 1.5 ml (Fig. 4B). Short exposure time appeared to 
play a critical role in the tolerance of these pressures in rats, as no respiratory or heart rate 
changes were observed (Table S1). In monkeys, the upper ICP threshold was limited to 50 mm 
Hg regardless of the exposure time and was related to immediate respiratory and cardiac 
complications (elevations of both rates followed by apnea) demanding resuscitation 
interventions. The cardiac complications can be somewhat attributed to the partial compression 
of cerebral vessels. Our recent study64 showed that in monkeys, the vascular factor contributed 
ca. 10% to compliance at pressures higher than the diastolic pressure (30-50 mm Hg under 
isoflurane anesthesia). 
 
Acute uncompensated ICP elevations suggest the minimal contribution of the drainage system 
and the primary role of the components of craniospinal compliance in adaptation to bolus 
administrations. These components involve mechanical entities capable of limited expansion 
and contraction. These physical factors of adaption contribute to the fast ICP elevation (<20 s) 
and relaxation (<200 s) times (Fig. 4C) suggesting low elasticity capacity of the involved 
components. This contrasts with physiological factors (drainage systems), for which significant 
activation times (1-15 min) were observed in rats (Fig. 3A). Although the exact locations of the 
entities contributing to the hydrostatic compliance have not yet been established, these 
hypothetically include membranes of the atlanto-occipital and atlanto-axial joint capsules, 
membranes covering openings (foramina), through which nerves and blood vessels exit the 
LMS, cerebral and spinal nerve sheaths, and fluid compartments of the inner ear. Whereas 
enlargement of the optic nerve’s meningeal sheath at elevated ICP is well documented65,66, the 
behavior of other nerves’ sheaths is yet to be established. In rodents, the nerve bundles exiting 
the cribriform plate are significantly more developed than those in primates and therefore their 
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contributions to volume and pressure attenuations may be expected at a higher degree. The 
role of the inner ear is mediated by the established communication via the cochlear aqueduct 
between the subarachnoid space of the posterior cranial fossa and the perilymphatic space of 
the cochlea. Widely open in most mammals and variably patent in humans (89% of young 
adults and 70% of older adults67), the cochlear aqueduct is situated in the petrous part of the 
temporal bone and therefore is incapable of any expansions. This rigid structure facilitates 
instant pressure transmission from the CSF to the fluids of the inner ear.68 However, compliant 
cochlear membranes (oval and round windows, tympanic, Reissner’s and basilar membranes) 
can plausibly accommodate some minor volume and pressure changes. Such compliance is 
believed to be critical for reducing the risk of structural damages to the cochlea due to relatively 
large and rapid ICP changes as a result of everyday events such as coughing and sneezing.69 
These functions of intra-cochlear hydromechanics underlie the novel emerging method of non-
invasive ICP monitoring based on the measurements of the tympanic membrane 
displacement.70 
 
How a system returns to the initial state after perturbations is an important parameter of its 
adaptive capacity and can also be indicative of the involved mechanisms. In this respect, ICP 
relaxation to the baseline level after low- and high-rate infusions was analyzed in rats and 
monkeys. Low-rate infusions characterized by the steady-state ICP demonstrated the longest 
pressure relaxation durations (141-1047 s in rats and 300±36 s in monkeys). This observation is 
consistent with the primary contribution of the slow-responsive CSF drainage system to the 
adaptation of this mode of administration. However, this contribution was gradually diminished 
with the increase of the infusion rate as indicated by the distortion of the shape of the relaxation 
curve by the appearance of the quick-relaxation phase (Phase I on Fig. 3C). Analysis of the 
purely bi-exponential relaxation curves specific for bolus injections in rats (Fig. S3 and Fig. S4) 
and monkeys (Fig. S6 and Fig. S7) clearly revealed the ever increasing role of the rapidly 
relaxing component with the raise in the ICP elevation magnitude (Fig. S9). This component can 
likely be attributed to the mechanisms of craniospinal compliance, very limited elasticity capacity 
of which explains the fast ICP elevation (2-20 s) and relaxation (9-172 s) times after bolus 
injections in rats. The gradual transition from the leading role of CSF drainage to compliance 
mechanisms was also illustrated by the change of the respective relationships between the 
relaxation time and the ICP elevation magnitude. Whereas it is linear at low-rate infusions (Fig. 
3D), it is reciprocally bi-exponential at high rates (Fig. 4C), with the transition occurring within 
the 15-20 mm Hg region. 
 
Comparison of the volume and pressure tolerance characteristics in rats and monkeys reveals 
many similarities though, it is essential the differences be emphasized. The same shape of the 
pressure-volume curves at low infusion rates suggests common underlying CSF drainage 
mechanisms. However, in rats these mechanisms could possibly be supplemented with 
lymphatic (or other) drainage pathways. Increased cardiac and respiratory rates at pressures 
approaching, or exceeding, the safety thresholds suggest the involvement of vascular reactivity, 
which in rats was significantly slower as evidenced by the time dependence of adversity. 
However, the most dramatic differences were observed in the tolerance of pressures exceeding 
the safety thresholds, which was specific for large-volume bolus injections. These pressures in 
monkeys (>50 mm Hg) immediately caused apnea, likely explained by the excessive pressure 
on the respiratory center in the medulla oblongata and pons. This effect in rats was not 
observed until the ICP of 200 mm Hg, which suggests fundamental physiological differences 
critical for translational studies.  
 
CONCLUSIONS 
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ICP monitoring is a valid method for determining safety thresholds for intrathecal therapy 
delivery. Craniospinal compliance and CSF drainage to the blood are the primary mechanisms 
of adaptation to elevated CSF pressures. However, their relative contributions, capacity, and 
physiological correlates are species-dependent and therefore caution should be used in 
extrapolation of the results between species. It is clear that volume and infusion rates define the 
duration and magnitude of CSF pressure elevation and both factors must be considered in the 
optimization of delivery strategies with respect to safety thresholds. While very limited elasticity 
capacity of the components of craniospinal compliance facilitates solute distribution in the CSF, 
it is important to pay attention to not exceed the safety thresholds at high-rate administrations. 
Notably, a pathological process or trauma may impact any of those thresholds and therefore the 
disease’s potential influence should be considered each time IT therapy delivery is to be used. 
Availability of methodologies enabling fast and reliable assessment of safety thresholds would 
significantly facilitate both preclinical research and, in a clinical setting, development of delivery 
strategies optimized for individual patients from both efficacy and safety perspectives.  
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SUPPLEMENTAL MATERIALS 
 
 
 
Figure S1. ICP measurements in rats. (A) Post-mortem CT scan of the atlanto-occipital junction 
verifying the catheter positioning in the cisterna magna. (B) A sketch of the equipment configuration, 
which includes the following components: (I) IT injection device (saline bag set at different heights, 
infusion pump, or syringe for manual injections), (II) Tuohy Borst adapter attached to the catheter inserted 
into the cisterna magna, with injection device connected to the adapter’s side arm, (III) micro-tip pressure 
sensor advanced into the cisterna magna through the adapter and catheter, (IV) data acquisition platform, 
(V) control and data analysis console, (VI) small-animal isoflurane anesthesia platform. 
 
 
 
 
Figure S2. ICP measurements in monkeys. A sketch of the equipment configuration. 
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Figure S3. ICP relaxation to the baseline value after bolus IT injections in the cisterna magna of a 
rat. Left to right: time-dependence curves of ICP (blue dots) and their bi-exponential fitting (red lines) after 
reaching the peak ICP as a result of administrations at 2.7±0.9 ml/min of 0.05 to 1.5 ml of saline. A time 
interval of 60s is shown. All data are normalized to 0 mm Hg baseline to account for differences in resting 
pressures. 
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Figure S4. Guggenheim linearization of the ICP relaxation after bolus IT injections in rats. Left to 
right: time dependence of the logarithm of difference between two ICP values on the ICP relaxation 
curves (Fig. S1), which are 10s (blue dots), 20s (red dots), and 30s (orange dots) apart, after 
administrations at 2.7±0.9 ml/min of 0.05 to 1.5 ml of saline. A time interval of 50s is shown. Bi-linear 
shape is indicative of bi-exponential character of the ICP relaxation. 
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Table S1. The effect of bolus IT injections on the heart and respiration rates in rats. Heart and 
respiration rates in beats per minute (bpm) are provided for different injected volumes (0.05-1.5 ml) during 
ICP elevation and relaxation phases. 
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Figure S5. Characterization of the pressure resistance in the IT injection port in monkeys. (A) Time 
dependence of pressure in the IT port measured ex-vivo for various injection flow rates from 0.01 ml/min 
to 8 ml/min. (B) Duration of the pressure elevation and relaxation phases as a function of the injection 
flow rate. 
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Figure S6. ICP relaxation to the baseline value after bolus IT injections in the lumbar ports of 
monkeys. Left to right: time-dependence curves of ICP (blue dots) and their bi-exponential fitting (red 
lines) after reaching the peak ICP as a result of administrations at 4.8±1.5, 1.7±0.5, and 2.1 ml/min of 1, 
3, and 5 ml of solutes, respectively. All the data are normalized to 0 mm Hg baseline to account for 
differences in resting pressures. 
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Fig. S7. Guggenheim linearization of the ICP relaxation after bolus IT injections in the lumbar 
ports of monkeys. Left to right: time dependence of the logarithm of difference between two ICP values 
on the ICP relaxation curves (Fig. S4), which are 60s (blue dots), 90s (red dots), and 120s (orange dots) 
apart, after administrations at 4.8±1.5, 1.7±0.5, and 2.1 ml/min of 1, 3, and 5 ml of solutes, respectively. A 
time interval of 300s is shown. Bi-linear shape is indicative of bi-exponential character of the ICP 
relaxation. 
 
 
 
Fig. S8. Dependence of the heart rate on the intracranial pressure caused in rats for extended 
durations (>10 min). The ICP was measured directly in the cisterna magna. The heart rate was obtained 
by conversion of the P1 frequency component of the ICP pulse wave into beats per minute. 
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Fig. S9. Contribution of the slow and fast processes to the ICP relaxation. The diagrams consist of 
the relative fractions of the slow (navy) and fast (orange) components of the bi-exponential function used 
to fit the ICP relaxation curves (Fig. S3 and Fig. S6) after bolus injections in rats (A) and monkeys (B). 
The fractions were obtained based on the pre-exponential coefficients. The slow and fast components of 
a bi-exponential function are characterized by longer and shorter half-lives, respectively. 
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